STOCK TITAN

Health Catalyst (HCAT) Stock News, Apr-Jun 2020

HCAT NASDAQ

Health Catalyst, Inc. reports developments tied to healthcare intelligence, data and analytics technology, and professional services for healthcare organizations. Company updates commonly cover operating results, revenue and Adjusted EBITDA guidance, and the use of AI-driven technology and domain expertise to support health systems across cost, clinical, and consumer performance.

Recurring news also includes leadership and board governance changes, shareholder-related board appointments, investor conference participation, and updates on strategic focus areas for its healthcare data platform, analytics applications, implementation, advisory, outsourcing, and improvement services.

Rhea-AI Summary

Health Catalyst, a leader in data and analytics for healthcare, announced their participation in two upcoming investor conferences. CEO Dan Burton will present at the William Blair 40th Annual Growth Stock Conference on June 10, 2020, at 1:20 p.m. CST, while CFO Patrick Nelli will speak at the Goldman Sachs 41st Annual Global Healthcare Conference on June 11, 2020, at 11:20 a.m. EST. The company supports healthcare organizations in making data-informed decisions, leveraging insights from over 100 million patient records.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
conferences
-
Rhea-AI Summary

Health Catalyst (Nasdaq: HCAT) reported its Q1 2020 financial results, revealing a 28% increase in total revenue, reaching $45.1 million compared to $35.2 million in Q1 2019. Technology revenue grew by 23% to $24.7 million, and professional services revenue surged 36% to $20.4 million. Despite the revenue growth, the company faced a net loss of $17.5 million, a 27% increase from the previous year. Adjusted EBITDA improved by 11% year-over-year, indicating resilience amid the COVID-19 pandemic. Health Catalyst remains committed to supporting healthcare organizations during these challenging times.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.39%
Tags
-
Rhea-AI Summary

Health Catalyst (HCAT) announced the appointment of Mark Templeton to its Board and the nominating and corporate governance committee, effective June 15, 2020. Templeton, former CEO of DigitalOcean, replaces Promod Haque after his term concludes at the annual stockholders meeting on June 12, 2020. Templeton brings over 20 years of experience, including 14 years as Citrix's CEO, where he significantly expanded the company. Dan Burton, CEO of Health Catalyst, expressed confidence in Templeton's capabilities to drive growth and support the company's mission to improve healthcare through data-informed decisions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.39%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.80%
Tags
conferences earnings

FAQ

What is the current stock price of Health Catalyst (HCAT)?

Health Catalyst (HCAT) last closed at $1.69.

What is the market cap of Health Catalyst (HCAT)?

The market cap of Health Catalyst (HCAT) is approximately $127.2M.